Adverse effects · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Adverse effects · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Adverse effects · psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes adverse effects compared with COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM (very low certainty).
1 finding from 1 review
Adverse effects · psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes adverse effects compared with COMBINATIONS: f. OLANZAPINE + MAGNESIUM VALPROATE (very low certainty).
1 finding from 1 review
Adverse effects · psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes adverse effects compared with COMBINATIONS: h. RISPERIDONE + CLONAZEPAM (very low certainty).
1 finding from 1 review
Adverse effects · psychosis‐induced aggression or agitation
HALOPERIDOL may leads to higher adverse effects compared with OTHER ANTIPSYCHOTICS: g. QUETIAPINE (low certainty).
1 finding from 1 review
Adverse effects · people with serious mental illness
HEALTH EDUCATION led to lower adverse Effects compared with HEALTH EMPOWERMENT EDUCATION; GRADE not reported.
1 finding from 1 review
Adverse effects ‐ any · patients with schizophrenia
1 finding from 1 review
Adverse effects‐death · patients with schizophrenia
1 finding from 1 review
Adverse effects/events · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Adverse effects/events · Women at risk of postnatal psychosis
1 finding from 1 review
Adverse effects ‐ death · patients with schizophrenia
1 finding from 1 review
Adverse effects (escape) · aggressive behaviour in schizophrenia
It is very uncertain whether structured risk assessment changes adverse effects (escape) compared with standard professional care (very low certainty).
1 finding from 1 review
Adverse effects: serious · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
1 finding from 1 review
Adverse effects (choking) · aggressive behaviour in schizophrenia
It is very uncertain whether structured risk assessment changes adverse effects (choking) compared with standard professional care (very low certainty).
1 finding from 1 review
Specific adverse events · psychosis‐induced aggression or agitation
HALOPERIDOL showed no clear difference in adverse effects: specific compared with COMBINATIONS: e. HALOPERIDOL + RISPERIDONE (low certainty).
1 finding from 1 review
Adverse effects: 1. Sedation · patients with schizophrenia
It is very uncertain whether ZUCLOPENTHIXOL DIHYDROCHLORIDE changes adverse effects: Sedation compared with PLACEBO (very low certainty).
1 finding from 1 review
Adverse effects: 1. Sedation · patients with schizophrenia
1 finding from 1 review
Adverse effects: specific ‐ seizure · patients with psychosis‐induced aggression or agitation
It is very uncertain whether CHLORPROMAZINE changes adverse effects ‐ seizures compared with HALOPERIDOL (very low certainty).
1 finding from 1 review
Adverse effects (fall down) · aggressive behaviour in schizophrenia
It is very uncertain whether structured risk assessment changes adverse effects (fall down) compared with standard professional care (very low certainty).
1 finding from 1 review